Posted by Michael Wonder on 13 Aug 2021
PBS arrangements for tocilizumab shortage
13 August 2021 - The sponsor of tocilizumab (Actemra) Roche has notified the TGA of shortages of multiple presentations of tocilizumab (Actemra) products due to global demand in response to the COVID-19 pandemic.
A joint advice statement for prescribers, prepared by the TGA in consultation with the Australia Rheumatology Association and Arthritis Australia is available.
